Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Omicron is more transmissible but may have milder symptoms for many people, expert says

Omicron is more transmissible but may have milder symptoms for many people, expert says

Two doses of Moderna COVID-19 vaccine highly effective against all SARS-CoV-2 variants

Two doses of Moderna COVID-19 vaccine highly effective against all SARS-CoV-2 variants

Evaluation of SARS-CoV-2 neutralizing antibodies in mothers and infants

Evaluation of SARS-CoV-2 neutralizing antibodies in mothers and infants

How SARS-CoV-2 affects the male reproductive system

How SARS-CoV-2 affects the male reproductive system

Evaluation of SARS-CoV-2 Omicron's immune evasion potential

Evaluation of SARS-CoV-2 Omicron's immune evasion potential

Signatures of rising SARS-CoV-2 Delta infections in New York

Signatures of rising SARS-CoV-2 Delta infections in New York

SARS-CoV-2 VOCs dependent on IFITM2 for efficient infection establishment

SARS-CoV-2 VOCs dependent on IFITM2 for efficient infection establishment

New Canadian study shows how SARS-CoV-2 transmission occurred in schools

New Canadian study shows how SARS-CoV-2 transmission occurred in schools

Weak T-cell clonal response to SARS-CoV-2 vaccination in IBD patients deficient in antibody-responders

Weak T-cell clonal response to SARS-CoV-2 vaccination in IBD patients deficient in antibody-responders

CDC researchers analyze the earliest batch of COVID-19 tests

CDC researchers analyze the earliest batch of COVID-19 tests

Researchers take advantage of virus' sweet tooth in the design of sugar-coated COVID-19 test strip

Researchers take advantage of virus' sweet tooth in the design of sugar-coated COVID-19 test strip

Factors associated with having data on SARS-CoV-2 infection and COVID-19 severity

Factors associated with having data on SARS-CoV-2 infection and COVID-19 severity

T-cell immune response in previously infected and vaccinated individuals effective against SARS-CoV-2 Omicron variant

T-cell immune response in previously infected and vaccinated individuals effective against SARS-CoV-2 Omicron variant

Novel bioinformatics pipeline for fast and scalable analysis of large viral phylogenies

Novel bioinformatics pipeline for fast and scalable analysis of large viral phylogenies

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

Receptor binding of SARS-CoV-2 Omicron variant compared to other variants

Receptor binding of SARS-CoV-2 Omicron variant compared to other variants

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Persistence of symptoms up to a year after hospitalization for COVID-19

Persistence of symptoms up to a year after hospitalization for COVID-19

Cell surface expression of SARS-CoV-2 nucleocapsid protein and its role in immunity

Cell surface expression of SARS-CoV-2 nucleocapsid protein and its role in immunity

Trajectory of SARS-CoV-2 vaccination and immunity examined in new model

Trajectory of SARS-CoV-2 vaccination and immunity examined in new model

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.